Transcriptional Regulation of the Human FasL Promoter-Enhancer Region
Authors:
- Alicia AlgecirasAAAlicia Algeciras
- Andrew D. BadleyABAndrew D. Badley
- Carlos V. PayaCPCarlos V. Paya
Open Access
- 1 February 1998
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (8) , 4416-4423
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological ToleranceImmunity, 1996
- Hyperproliferation and Dysregulation ofIL-4 Expression in NF-ATp-Deficient MiceImmunity, 1996
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Fas-mediated cytotoxicity by freshly isolated natural killer cells.Journal of Experimental Medicine, 1995
- Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationNature, 1995
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genesImmunology Today, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991